ArticleJAMA network open2026
Perceived Risk of Fentanyl Use Among US Adolescents.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Youth awareness of the dangers of fentanyl use has become increasingly important as adolescent overdose mortality has increased in recent years. Objective: To present US nationally representative estimates of perceived risk of fentanyl use among adolescents. Design, Setting, and Participants: This cross-sectional survey study of 8th-, 10th-, and 12th-grade students in 2025 included a nationally representative sample of students in the 48 contiguous US states who filled out surveys in class at school. Data were from the 2025 Monitoring the Future study, analyzed between January 15 and May 11, 2026. Main Outcomes and Measures: Responses to questions on perceived risk of experimental (trying once or twice), occasional, and regular fentanyl use. Analyses used multiple imputation and Poisson regression models. Results: In this study, 3820 adolescents self-reported their perceived risk of fentanyl use (32.8% [1156] in 8th, 34.7% [1482] in 10th, and 32.5% [1182] in 12th grade; by demographic category, participants were 50.1% [1843] female; 35.2% [1185] Hispanic, 15.2% [544] non-Hispanic Black, 36.1% [1507] non-Hispanic White, and 13.5% [487] non-Hispanic other race). Less than half of 8th-grade students (47.8% [549]) attributed great risk to experimental use, while 57.2% (660) attributed great risk to occasional use, and 66.5% (768) attributed great risk to regular use. For students in 10th grade, 63.6% (925) attributed great risk to experimental use, 71.5% (1061) attributed great risk to occasional use, and 77.3% (1144) attributed great risk to regular use. For students in 12th grade, 69.8% (834) attributed great risk to experimental use, 78.5% (929) attributed great risk to occasional use, and 84.8% (1003) attributed great risk to regular use. Students in rural areas had the highest levels of perceived risk in 8th and 10th grade. Non-Hispanic White students were most likely to ascribe great risk to fentanyl use in all grades across all 3 categories of fentanyl use (experimental, occasional, and regular). In 8th grade, Hispanic students had the lowest levels of perceived risk for all 3 fentanyl categories, and in 10th and 12th grade, non-Hispanic Black students had the lowest levels. Conclusions and Relevance: In this survey study, an appreciable portion of adolescents-particularly the younger ones-were not aware of the dangers of fentanyl use. Clinicians, parents, schools, and public education programs all have important roles in communicating the potentially life-threatening risks of fentanyl misuse to adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.